JP2006508099A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508099A5
JP2006508099A5 JP2004548934A JP2004548934A JP2006508099A5 JP 2006508099 A5 JP2006508099 A5 JP 2006508099A5 JP 2004548934 A JP2004548934 A JP 2004548934A JP 2004548934 A JP2004548934 A JP 2004548934A JP 2006508099 A5 JP2006508099 A5 JP 2006508099A5
Authority
JP
Japan
Prior art keywords
cpn10
animal
derivative
effective amount
pharmaceutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004548934A
Other languages
English (en)
Japanese (ja)
Other versions
JP4716731B2 (ja
JP2006508099A (ja
Filing date
Publication date
Priority claimed from AU2002952492A external-priority patent/AU2002952492A0/en
Application filed filed Critical
Publication of JP2006508099A publication Critical patent/JP2006508099A/ja
Publication of JP2006508099A5 publication Critical patent/JP2006508099A5/ja
Application granted granted Critical
Publication of JP4716731B2 publication Critical patent/JP4716731B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004548934A 2002-11-06 2003-11-06 シャペロニン10免疫抑制 Expired - Fee Related JP4716731B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002952492 2002-11-06
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010286005A Division JP2011088920A (ja) 2002-11-06 2010-12-22 シャペロニン10免疫抑制

Publications (3)

Publication Number Publication Date
JP2006508099A JP2006508099A (ja) 2006-03-09
JP2006508099A5 true JP2006508099A5 (enExample) 2007-04-12
JP4716731B2 JP4716731B2 (ja) 2011-07-06

Family

ID=28795882

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004548934A Expired - Fee Related JP4716731B2 (ja) 2002-11-06 2003-11-06 シャペロニン10免疫抑制
JP2010286005A Pending JP2011088920A (ja) 2002-11-06 2010-12-22 シャペロニン10免疫抑制

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010286005A Pending JP2011088920A (ja) 2002-11-06 2010-12-22 シャペロニン10免疫抑制

Country Status (16)

Country Link
US (3) US7618935B2 (enExample)
EP (3) EP2255824B1 (enExample)
JP (2) JP4716731B2 (enExample)
KR (1) KR101088740B1 (enExample)
CN (1) CN100525832C (enExample)
AT (1) ATE489963T1 (enExample)
AU (1) AU2002952492A0 (enExample)
CA (1) CA2505141C (enExample)
CY (1) CY1110972T1 (enExample)
DE (1) DE60335202D1 (enExample)
DK (1) DK1569679T3 (enExample)
ES (1) ES2351993T3 (enExample)
NZ (1) NZ540433A (enExample)
PT (1) PT1569679E (enExample)
SI (1) SI1569679T1 (enExample)
WO (1) WO2004041300A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007517808A (ja) 2004-01-16 2007-07-05 キュビオ リミテッド Toll様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン10調節
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
EP1906989A4 (en) 2005-07-11 2009-08-19 Cbio Ltd IMMUNOMODULATION INDUCED BY CHAPERONIN 10
EP2463307A1 (en) 2005-08-31 2012-06-13 CBIO Limited Modified chaperonin 10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CA2626692A1 (en) * 2005-10-20 2007-04-26 Cbio Limited Treatment of hypersensitivity
MX2008011167A (es) 2006-03-02 2008-11-12 Cbio Ltd Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos.
CA2720617A1 (en) * 2008-04-11 2009-10-15 Cbio Limited Modified cpn10 and prr signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
US10842913B2 (en) 2012-12-10 2020-11-24 Allergan Pharmaceuticals International Limited Scalable three-dimensional elastic construct manufacturing
RU2677637C2 (ru) 2013-08-13 2019-01-18 Эластаджен Пти Лтд Регенерация поврежденной ткани

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
WO1995015338A1 (en) 1993-11-30 1995-06-08 The University Of Queensland Chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
EP1218030A4 (en) 1999-09-10 2004-09-15 Univ Fordham METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRANSPLANT REJECTION BY USING HEAT SHOCK PROTEINS
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Similar Documents

Publication Publication Date Title
US7420033B2 (en) Composition of lactoferrin related peptides and uses thereof
US8454967B2 (en) Compositions and methods for modulating the immune system
TW200524626A (en) Treatment of HCV disorders
JPH1180026A (ja) 新規免疫抑制剤、その使用方法およびその同定方法
US20250152665A1 (en) Mutant Peptides And Methods Of Treating Subjects Using The Same
JP5758806B2 (ja) シクロウンデカデプシペプチド化合物および医薬としてのその化合物の使用
CN101189022B (zh) 促肾上腺皮质激素类似物以及相关方法
CA2505141A1 (en) Chaperonin 10 immunosuppression
CN1997384A (zh) 使用补体C5a受体调节剂治疗神经系统病症
JP2007513053A (ja) 間質性肺感染症治療用の生物学的活性を有する血管作用性小腸ペプチドなる物質
JPH10501003A (ja) 免疫調節作用を有する新規ペプチド
JP2005534634A (ja) 治療方法
Muramatsu et al. Chimerism studies as an approach for the induction of tolerance to extremity allografts
US20070021329A1 (en) Treatment of hypersensitivity conditions
JP2006514015A5 (enExample)
JP2006514015A (ja) 免疫寛容を誘導するためのジアミド誘導体と免疫抑制剤との組み合わせ
CN108367052A (zh) 用于治疗组织损伤的药物组合物
WO2004003007A1 (fr) Peptides se liant a des cellules non lymphocytaires, et utilisations correspondantes
CN101919832A (zh) 高级脂肪酸衍生物的免疫抑制剂及其应用
ES2269825T3 (es) Composicion y procedimiento para el tratamiento del rechazo de aloinjerto.
Calne Organ transplantation with special emphasis on Cyclosporin A
US8138170B2 (en) Immunosuppressive Ningalin compounds
Benhaim et al. Reconstructive allotransplantation: current research and future clinical applications
Rüther et al. suppressants and Immunoinductors
Barker et al. The origin of clinical organ transplantation revisited